CDKN2A and pancreatic neoplasm: Genetic syndromes, such as those resulting from inherited mutations in genes like STK11, BRCA1, BRCA2, PALB2, CDKN2A, and DNA repair genes, notably elevate the risk of pancreatic cancer, particularly in individuals with a family history of pancreatic cancer among first-degree relatives.